Micromet Inc (MITI) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Micromet Inc (MITI)

An SI Board Since February 2006

Posts	SubjectMarks	Bans	Symbol
196	15	0	MITI

Emcee: dr.praveen	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
46	Curis, Inc. Agrees to Settlement with Micromet AG Tuesday October 3, 8:00 am ET	nigel bates	-	10/3/2006
45	Hi tuck, I kind of stopped following them actively till I see the P2 results co	dr.praveen	-	8/6/2006
44	The Bites have quite a short serum half-life at two hours. What is meant in the	tuck	-	8/5/2006
43	Thanks, it does indeed seem you did your homework long before I stumbled over he	tuck	-	8/3/2006
42	Hi Tuck, I used to have a large position in Micromet and made more than a doubl	dr.praveen	-	8/3/2006
41	I only have it, and only a little, because it was cheap and they have some novel	keokalani'nui	-	8/3/2006
40	Well, I can't find diddly on trial design in the PRs, which are exceptionall	tuck	-	8/3/2006
39	For some reason, Loonie Bros. has MicroMet as an underweight (I don't have a	tuck	-	8/3/2006
38	MedImmune and Micromet Report on Novel Anti-cancer BiTE(R) Friday July 21, 3:08	keokalani'nui	-	7/21/2006
37	Study Supports Neutralization of GM-CSF as Novel Therapeutic Approach in Arthrit	dr.praveen	-	7/8/2006
36	Preliminary Clinical Data of MT103 (MEDI-538), a CD19-specific BiTE(R), Indicate	dr.praveen	-	6/19/2006
35	Study Supports Potential of Micromet's Human Antibody MT203 As Novel Anti-In	dr.praveen	-	6/15/2006
34	First Clinical Data of MT103 (MEDI-538), a CD19-specific BiTE(R), to Be Presente	dr.praveen	-	6/1/2006
33	New Study Demonstrates Prognostic Value of the EpCAM Tumor Antigen in Ovarian Ca	dr.praveen	-	5/30/2006
32	Micromet and CancerVax Complete Merger To Form Micromet, Inc. Friday May 5, 6:44	dr.praveen	-	5/6/2006
31	CancerVax Stockholders Approve Merger With Micromet Wednesday May 3, 2:29 pm ET	dr.praveen	-	5/4/2006
30	Looked at Aphton years and years ago and fortunately took a pass. It seems I	keokalani'nui	-	4/10/2006
29	Hi Wilder, Do you follow Aphton? aphton.com I heard their IGN101 cancer vacci	dr.praveen	-	4/10/2006
28	The proposed vote of merger between CNVX and MITI will be held on... May 3, 200	dr.praveen	-	4/6/2006
27	April 3rd, 2006 Preclinical Study Supports Therapeutic Potential of Micromet’s N	dr.praveen	-	4/6/2006
26	CancerVax Presents Preclinical Data Demonstrating Tumor Inhibition by D93, a Nov	dr.praveen	-	4/4/2006
25	Not sure Wilder...! Might be any addn data compilation or priority for micromet&	dr.praveen	-	4/3/2006
24	Back in business for the moment, yes, but what's with this? <i>Cancer	keokalani'nui	-	4/3/2006
23	CancerVax Announces FDA Approval of IND for Novel Anti-Angiogenic Antibody D93 M	dr.praveen	-	4/3/2006
22	March 2nd, 2006 Micromet Study Provides New Insight into Dosing Requirements for	dr.praveen	-	3/3/2006

Go to reply# or date (mm/dd/yy):